Iodine in PDB 3vg6: Barium Derivative of Human Lfabp
Protein crystallography data
The structure of Barium Derivative of Human Lfabp, PDB code: 3vg6
was solved by
A.Sharma,
M.Yogavel,
A.Sharma,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
8.00 /
2.22
|
Space group
|
P 21 21 21
|
Cell size a, b, c (Å), α, β, γ (°)
|
30.216,
57.240,
74.491,
90.00,
90.00,
90.00
|
R / Rfree (%)
|
20.9 /
29.5
|
Other elements in 3vg6:
The structure of Barium Derivative of Human Lfabp also contains other interesting chemical elements:
Iodine Binding Sites:
The binding sites of Iodine atom in the Barium Derivative of Human Lfabp
(pdb code 3vg6). This binding sites where shown within
5.0 Angstroms radius around Iodine atom.
In total 5 binding sites of Iodine where determined in the
Barium Derivative of Human Lfabp, PDB code: 3vg6:
Jump to Iodine binding site number:
1;
2;
3;
4;
5;
Iodine binding site 1 out
of 5 in 3vg6
Go back to
Iodine Binding Sites List in 3vg6
Iodine binding site 1 out
of 5 in the Barium Derivative of Human Lfabp
Mono view
Stereo pair view
|
A full contact list of Iodine with other atoms in the I binding
site number 1 of Barium Derivative of Human Lfabp within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:I132
b:44.9
occ:0.50
|
I
|
A:IOD132
|
0.0
|
44.9
|
0.5
|
I
|
A:IOD132
|
1.5
|
41.7
|
0.5
|
I
|
A:IOD134
|
3.2
|
52.0
|
0.3
|
CE
|
A:MET113
|
3.7
|
32.1
|
1.0
|
CB
|
A:THR73
|
3.9
|
31.5
|
1.0
|
CD1
|
A:ILE22
|
4.0
|
43.8
|
1.0
|
CE1
|
A:PHE95
|
4.1
|
26.4
|
1.0
|
CE2
|
A:PHE18
|
4.1
|
36.3
|
1.0
|
CD1
|
A:ILE98
|
4.2
|
31.4
|
1.0
|
N
|
A:MET74
|
4.2
|
32.5
|
1.0
|
CB
|
A:MET74
|
4.3
|
33.4
|
0.5
|
CG2
|
A:THR73
|
4.5
|
29.9
|
1.0
|
CZ
|
A:PHE18
|
4.5
|
36.1
|
1.0
|
CG1
|
A:ILE22
|
4.6
|
44.0
|
1.0
|
OG1
|
A:THR73
|
4.6
|
31.5
|
1.0
|
CZ
|
A:PHE95
|
4.6
|
26.1
|
1.0
|
CG2
|
A:ILE22
|
4.7
|
43.8
|
1.0
|
CB
|
A:ILE22
|
4.7
|
44.4
|
1.0
|
CA
|
A:THR73
|
4.9
|
31.3
|
1.0
|
CA
|
A:MET74
|
4.9
|
33.1
|
0.5
|
CG
|
A:MET74
|
4.9
|
35.5
|
0.5
|
|
Iodine binding site 2 out
of 5 in 3vg6
Go back to
Iodine Binding Sites List in 3vg6
Iodine binding site 2 out
of 5 in the Barium Derivative of Human Lfabp
Mono view
Stereo pair view
|
A full contact list of Iodine with other atoms in the I binding
site number 2 of Barium Derivative of Human Lfabp within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:I132
b:41.7
occ:0.50
|
I
|
A:IOD132
|
0.0
|
41.7
|
0.5
|
I
|
A:IOD132
|
1.5
|
44.9
|
0.5
|
N
|
A:MET74
|
3.4
|
32.5
|
1.0
|
CE
|
A:MET113
|
3.5
|
32.1
|
1.0
|
CB
|
A:MET74
|
3.6
|
33.4
|
0.5
|
CB
|
A:THR73
|
3.7
|
31.5
|
1.0
|
CG
|
A:MET74
|
3.9
|
35.5
|
0.5
|
CG
|
A:PLM150
|
4.0
|
31.1
|
0.7
|
CA
|
A:MET74
|
4.1
|
33.1
|
0.5
|
CA
|
A:THR73
|
4.2
|
31.3
|
1.0
|
C
|
A:THR73
|
4.3
|
32.0
|
1.0
|
I
|
A:IOD134
|
4.4
|
52.0
|
0.3
|
CG2
|
A:THR73
|
4.4
|
29.9
|
1.0
|
CE1
|
A:PHE95
|
4.6
|
26.4
|
1.0
|
CE
|
A:PLM150
|
4.6
|
32.2
|
0.7
|
OG1
|
A:THR73
|
4.7
|
31.5
|
1.0
|
CZ
|
A:PHE95
|
4.7
|
26.1
|
1.0
|
CE2
|
A:PHE18
|
4.7
|
36.3
|
1.0
|
CD1
|
A:ILE22
|
4.8
|
43.8
|
1.0
|
CF
|
A:PLM150
|
4.9
|
32.2
|
0.7
|
SD
|
A:MET113
|
4.9
|
33.7
|
1.0
|
|
Iodine binding site 3 out
of 5 in 3vg6
Go back to
Iodine Binding Sites List in 3vg6
Iodine binding site 3 out
of 5 in the Barium Derivative of Human Lfabp
Mono view
Stereo pair view
|
A full contact list of Iodine with other atoms in the I binding
site number 3 of Barium Derivative of Human Lfabp within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:I133
b:36.4
occ:0.30
|
OG1
|
A:THR51
|
3.0
|
30.5
|
1.0
|
O
|
A:GLU40
|
3.5
|
27.9
|
1.0
|
O
|
A:LYS49
|
3.6
|
27.1
|
1.0
|
N
|
A:THR51
|
3.8
|
28.7
|
1.0
|
C
|
A:LYS49
|
3.9
|
27.4
|
1.0
|
CG2
|
A:VAL42
|
3.9
|
24.8
|
1.0
|
CA
|
A:PHE50
|
4.0
|
28.2
|
1.0
|
CB
|
A:THR51
|
4.0
|
29.6
|
1.0
|
C
|
A:GLU40
|
4.1
|
27.2
|
1.0
|
C
|
A:PHE50
|
4.1
|
28.7
|
1.0
|
CB
|
A:LYS49
|
4.1
|
28.1
|
1.0
|
N
|
A:PHE50
|
4.1
|
27.4
|
1.0
|
CB
|
A:GLU40
|
4.2
|
27.7
|
1.0
|
NE2
|
A:GLN60
|
4.3
|
31.7
|
0.5
|
N
|
A:VAL42
|
4.5
|
25.2
|
1.0
|
CA
|
A:THR51
|
4.5
|
29.1
|
1.0
|
N
|
A:ILE41
|
4.7
|
26.8
|
1.0
|
OE1
|
A:GLU40
|
4.7
|
36.9
|
1.0
|
CA
|
A:LYS49
|
4.7
|
27.7
|
1.0
|
CA
|
A:ILE41
|
4.8
|
26.0
|
1.0
|
CB
|
A:VAL42
|
4.8
|
25.0
|
1.0
|
C
|
A:ILE41
|
4.8
|
25.4
|
1.0
|
CA
|
A:GLU40
|
4.8
|
28.1
|
1.0
|
CD
|
A:GLN60
|
4.9
|
32.2
|
0.5
|
O
|
A:PHE50
|
5.0
|
29.1
|
1.0
|
|
Iodine binding site 4 out
of 5 in 3vg6
Go back to
Iodine Binding Sites List in 3vg6
Iodine binding site 4 out
of 5 in the Barium Derivative of Human Lfabp
Mono view
Stereo pair view
|
A full contact list of Iodine with other atoms in the I binding
site number 4 of Barium Derivative of Human Lfabp within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:I134
b:52.0
occ:0.27
|
CD
|
A:LYS96
|
2.9
|
29.3
|
0.5
|
CE
|
A:LYS96
|
2.9
|
30.2
|
0.5
|
I
|
A:IOD132
|
3.2
|
44.9
|
0.5
|
OG1
|
A:THR73
|
3.6
|
31.5
|
1.0
|
CB
|
A:THR73
|
3.9
|
31.5
|
1.0
|
CD1
|
A:ILE98
|
4.0
|
31.4
|
1.0
|
CB
|
A:ILE22
|
4.2
|
44.4
|
1.0
|
CG2
|
A:THR73
|
4.2
|
29.9
|
1.0
|
CG
|
A:LYS96
|
4.3
|
29.6
|
0.5
|
NZ
|
A:LYS96
|
4.3
|
30.4
|
0.5
|
I
|
A:IOD132
|
4.4
|
41.7
|
0.5
|
CD1
|
A:ILE22
|
4.4
|
43.8
|
1.0
|
CG2
|
A:ILE22
|
4.5
|
43.8
|
1.0
|
CE1
|
A:PHE95
|
4.5
|
26.4
|
1.0
|
OG1
|
A:THR75
|
4.5
|
32.1
|
1.0
|
CG2
|
A:THR75
|
4.6
|
31.0
|
1.0
|
O
|
A:ILE22
|
4.7
|
44.8
|
1.0
|
CB
|
A:LYS96
|
4.8
|
29.2
|
0.5
|
CG
|
A:LYS96
|
4.8
|
29.6
|
0.5
|
CD1
|
A:PHE95
|
4.8
|
25.9
|
1.0
|
CG1
|
A:ILE22
|
4.9
|
44.0
|
1.0
|
CB
|
A:LYS96
|
4.9
|
29.2
|
0.5
|
NZ
|
A:LYS96
|
4.9
|
31.6
|
0.5
|
|
Iodine binding site 5 out
of 5 in 3vg6
Go back to
Iodine Binding Sites List in 3vg6
Iodine binding site 5 out
of 5 in the Barium Derivative of Human Lfabp
Mono view
Stereo pair view
|
A full contact list of Iodine with other atoms in the I binding
site number 5 of Barium Derivative of Human Lfabp within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:I135
b:39.1
occ:0.28
|
NZ
|
A:LYS121
|
2.9
|
40.5
|
1.0
|
OG
|
A:SER11
|
3.4
|
33.2
|
1.0
|
OE2
|
A:GLU13
|
3.8
|
46.4
|
1.0
|
CG
|
A:GLU13
|
3.8
|
39.5
|
1.0
|
CA
|
A:GLN12
|
3.8
|
34.6
|
1.0
|
CD1
|
A:ILE123
|
3.9
|
26.1
|
1.0
|
N
|
A:GLN12
|
3.9
|
34.0
|
1.0
|
C
|
A:GLN12
|
3.9
|
35.3
|
1.0
|
N
|
A:GLU13
|
4.0
|
35.9
|
1.0
|
C
|
A:SER11
|
4.0
|
33.2
|
1.0
|
O
|
A:LYS121
|
4.1
|
26.0
|
1.0
|
CG1
|
A:ILE123
|
4.1
|
24.4
|
1.0
|
O
|
A:SER11
|
4.1
|
33.2
|
1.0
|
CB
|
A:SER11
|
4.2
|
32.9
|
1.0
|
CE
|
A:LYS121
|
4.2
|
37.9
|
1.0
|
CD
|
A:GLU13
|
4.3
|
43.8
|
1.0
|
CG
|
A:LYS121
|
4.4
|
29.8
|
1.0
|
CB
|
A:GLU13
|
4.5
|
36.8
|
1.0
|
O
|
A:GLN12
|
4.5
|
35.7
|
1.0
|
C
|
A:LYS121
|
4.6
|
26.1
|
1.0
|
CB
|
A:ILE123
|
4.7
|
24.0
|
1.0
|
CD
|
A:LYS121
|
4.7
|
34.7
|
1.0
|
N
|
A:ILE123
|
4.7
|
24.5
|
1.0
|
CA
|
A:SER11
|
4.8
|
32.8
|
1.0
|
CA
|
A:GLU13
|
4.8
|
36.6
|
1.0
|
CB
|
A:LYS121
|
4.9
|
27.1
|
1.0
|
|
Reference:
A.Sharma,
M.Yogavel,
A.Sharma.
Utility of Anion and Cation Combinations For Phasing of Protein Structures. J.Struct.Funct.Genom. V. 13 135 2012.
ISSN: ISSN 1345-711X
PubMed: 22562242
DOI: 10.1007/S10969-012-9137-3
Page generated: Sun Aug 11 17:01:59 2024
|